Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.
about
Intravascular optical imaging technology for investigating the coronary arteryDrug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive ReviewExpansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samplesManagement of Percutaneous Coronary Intervention Complications.Angiographically confirmed stent thrombosis in contemporary practice: insights from intravascular ultrasound.A Randomized Comparison between Everolimus-Eluting Stent and Cobalt Chromium Stent in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Using Routine Intravenous Eptifibatide: The X-MAN (XieIntracoronary optical coherence tomography: a comprehensive review clinical and research applicationsCompensatory Enlargement of Ossabaw Miniature Swine Coronary Arteries in Diffuse Atherosclerosis.Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stentsImpact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent ImplantationNatural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-upEvaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography.Optical coherence tomography endpoints in stent clinical investigations: strut coverage.New strategies in the treatment of coronary bifurcations.Very Late Stent Thrombosis of Sirolimus-eluting Stent 59 Months After Implantation: A First Report from The Middle-East and Review of Literature.Restenosis after PCI. Part 2: prevention and therapy.Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials.Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.Long-term safety of drug-eluting stents.Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction.Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.Dextran or Saline Can Replace Contrast for Intravascular Optical Coherence Tomography in Lower Extremity Arteries.Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome.Intravascular ultrasound-guided drug-eluting stent implantation.The comparative safety of bare-metal and drug-eluting intracoronary stents.Coronary aneurysm occurring late after drug-eluting stent implantationErosion/malapposition of a sirolimus eluting stent - optical coherence tomography image - a case reportAutomatic stent strut detection in intravascular optical coherence tomographic pullback runs.Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.Optical Coherence Tomography Imaging: Novel Insights into the Vascular Response After Coronary Stent ImplantationFrequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound.Late Incomplete stent apposition is associated with late/very late stent thrombosis: A meta-analysis.Combined use of optical coherence tomography and intravascular ultrasound imaging for the evaluation of stent thrombosis.Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.Enlarged coronary artery pseudoaneurysm after drug-eluting stent implantation.A prospective intravascular ultrasound investigation of the necessity for and efficacy of postdilation beyond nominal diameter of 3 current generation DES platforms for the percutaneous treatment of the left main coronary artery.Angiographic and clinical performance of polymer-free biolimus-eluting stent in patients with ST-segment elevation acute myocardial infarction in a metropolitan public hospital: The BESAMI MUCHO study.Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.Role of residual acute stent malapposition in percutaneous coronary interventions.Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
P2860
Q26852822-23822CEB-63DD-4E7B-880E-A113D18895EFQ28068387-6E428231-13F7-4D1E-8064-BF6281B10BCFQ28479223-B56C6E45-21DA-4CB2-875F-B62B2168648AQ30400083-C48C2B5F-574E-49BA-891C-E5BBDBC319B5Q30415522-AC091C70-353C-4210-85EF-6E1D4125C679Q33848052-4D8D4D75-810B-42A3-9B0E-D90F251DA8B4Q33959574-49241DF4-DBA0-4B22-A09C-5A3C1BA12E32Q35124809-7B831F00-B43D-49B0-BCD4-D58B2A567D34Q35932110-AFA62187-5A7C-4436-A4A4-C4F2CBD2160AQ36240137-79E5C0FF-BBFD-436C-9A37-7654342FF330Q37081798-88E21A80-1A7C-4DEC-9805-FE5231255563Q37330704-5566F3E1-363A-433C-BF1B-76969C007B5FQ37851899-625BC593-92C2-4BC0-BB01-0D00901E57F4Q37871912-339F371B-BC37-479B-AA20-9439E59A2F5CQ37897983-74DC9EF2-0B8A-4881-B1F0-5F4BD1F71479Q37944416-56F123B6-80D4-44AC-91F0-E7588C24AEFDQ38010382-E387C5C3-3588-4CD5-B896-359B815132A1Q38063290-40687488-DEA5-4FE5-A521-AA6240C48FC1Q38153786-1B62C99C-FAB6-4B11-94D0-D0BC0DA06787Q38280156-71B8348E-F65A-4321-A285-A348E0945521Q38381419-B619FA56-D3B1-48B4-98D8-FF567E50141EQ38390456-7A5B201B-A6A1-45FF-A348-0F65F384ED0BQ38699758-17327917-F4B5-46C4-B4C0-29CDA86018BDQ39002367-EB9D20B2-5A46-42CB-9348-EEF85D3A2334Q39840291-B83C526A-CF46-4583-BE3E-3287935446F3Q40545273-5B6E672A-8D3E-477B-A78A-2EAF666546E5Q41829610-1A0AA37B-9AAC-40A9-B950-382885772809Q42018266-306C33AD-F422-4131-9840-9139A9D415C2Q42133869-AAF05E26-52D1-482B-BB42-8DE3AA2DF1C4Q42154709-D0FD11FE-FBF6-4BC0-9807-6AEA63A1E4B0Q43880648-B6AF86FE-10EC-4F2A-B3D5-17C0DF298C07Q44079838-BCDE1D70-A2F9-4712-91BD-EF4ECD2C4BB4Q44262431-A04F4A92-4833-4F71-82B4-5C43AB1753EDQ44672104-F6E2D21C-F182-44DE-8E79-32BED8CB54F6Q45824729-2240ED0C-B23B-4767-A9EC-1614606846F2Q45850646-5DF84D10-2245-4E18-ACF5-32C3B1B3BC6DQ47853894-730822A1-7C2F-4B44-8E85-9DA5C27C9829Q47984223-A2BBD6DE-288E-4214-8C1C-57AE883F1108Q48122977-E1FA5E99-C6FA-48F3-BE4C-9FFB080227F7Q50437651-52F0C8D9-0C0D-4099-B31B-E74467EF968A
P2860
Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Late stent malapposition risk ...... es with late stent thrombosis.
@en
Late stent malapposition risk ...... es with late stent thrombosis.
@nl
type
label
Late stent malapposition risk ...... es with late stent thrombosis.
@en
Late stent malapposition risk ...... es with late stent thrombosis.
@nl
prefLabel
Late stent malapposition risk ...... es with late stent thrombosis.
@en
Late stent malapposition risk ...... es with late stent thrombosis.
@nl
P2093
P2860
P356
P1476
Late stent malapposition risk ...... es with late stent thrombosis.
@en
P2093
Ayman K M Hassan
Bas L van der Hoeven
J Wouter Jukema
Jaapjan D Snoep
Josepha W M Plevier
Martin J Schalij
Sandrin C Bergheanu
Theo Stijnen
P2860
P304
P356
10.1093/EURHEARTJ/EHN553
P577
2009-01-21T00:00:00Z